The Laxmi Dental IPO officially opened for bidding today, January 13, 2025, marking a significant step for India’s only end-to-end integrated dental product company. With a robust price band of ₹407 to ₹428 per share, this ₹698.06 crore IPO has caught the attention of investors. The public issue comprises a mix of fresh equity shares worth ₹138 crore and an Offer for Sale (OFS) of ₹560.06 crore, with the shares set to list on both BSE and NSE.
With a growing market focus on dental aesthetics and metal-free products, the IPO is already generating strong interest. Here’s a detailed look into the key aspects of this IPO.
Key Highlights of Laxmi Dental IPO
| Attribute | Details |
|---|---|
| IPO Dates | January 13–15, 2025 |
| Price Band | ₹407 to ₹428 per equity share |
| IPO Size | ₹698.06 crore |
| Fresh Issue | ₹138 crore |
| Offer for Sale (OFS) | ₹560.06 crore |
| Lot Size | 33 shares per lot |
| IPO Registrar | Link Intime India Private Limited |
| Listing Date | Likely January 20, 2025 |
| Lead Managers | Nuvama Wealth, Motilal Oswal, SBI Capital Markets |
Laxmi Dental IPO Subscription Status
By 11:18 AM on Day 1, the IPO had been subscribed 1.11 times, showing strong interest:
- Retail Investors: Subscribed 3.83 times
- Non-Institutional Investors (NII): Subscribed 1.52 times
- Qualified Institutional Buyers (QIBs): Yet to see significant action
GMP Signals Positive Listing Potential
The grey market premium (GMP) for Laxmi Dental IPO stood at ₹161 per share on Day 1, indicating a potential listing price of ₹589, a 37.62% premium over the upper issue price of ₹428.
Expert Analysis: Should You Invest in Laxmi Dental IPO?
Why Analysts Are Bullish
- Revenue and Profit Growth:
Laxmi Dental’s revenue and EBITDA grew at a CAGR of 18.9% and 109.6% respectively, between FY2022 and FY2024. Its EBITDA margins improved from 4% in FY22 to 19.5% in H1FY25, demonstrating significant operational efficiencies. - Niche Market Leader:
The company is uniquely positioned as India’s only integrated dental product provider, catering to the pharmaceutical and healthcare industries with a focus on B2B2C models. - Export Potential:
Plans to increase export revenue from the current 0.5% to 15%–20% by 2027 add to its growth story. - Valuation Perspective:
Analysts view the IPO’s valuation at P/E of 76.8x (adjusted for exceptional items) as high but justified given its niche positioning and growth prospects.
Concerns for Investors
- High Proportion of OFS:
With 80% of the issue via OFS, existing stakeholders are cashing out, which may raise concerns for long-term investors. - Aggressive Pricing:
While the IPO is attractively positioned, its valuation is considered aggressive compared to industry peers.
Recommendations
- Short-Term Traders: Beneficial due to high GMP and robust demand.
- Long-Term Investors: Suitable for those with a risk appetite, given the growth potential in dental aesthetics and healthcare products.
Financial Performance: Strong Growth
| Metric | FY22 | FY24 (H1) |
|---|---|---|
| Revenue (₹ Cr) | ₹163.84 | ₹195.26 |
| Net Worth (₹ Cr) | ₹96.54 | ₹134.52 |
| EBITDA Margin | 4.0% | 19.5% |
The company’s assets have grown by 40% YoY, demonstrating solid financial health.
Why Laxmi Dental IPO Stands Out
Laxmi Dental operates in a niche but growing market segment, with significant demand for dental aesthetics and metal-free products. Its focus on innovation and a B2B2C model positions it as a promising player in the healthcare industry.
Conclusion: Is Laxmi Dental IPO Worth Investing In?
For risk-tolerant investors, Laxmi Dental IPO offers an exciting opportunity to tap into a specialized, high-growth industry. With strong financials, operational efficiencies, and export expansion plans, this IPO holds potential for both short-term gains and long-term returns.
However, the high OFS proportion and aggressive valuation necessitate a cautious approach. Investors should consult financial advisors to align this investment with their risk tolerance and portfolio strategy.
Disclaimer: The information above is based on expert analyses and market trends. Always consult a certified financial advisor before making investment decisions.
Click here to know more.
